KLH: Clinical Trials

2 trials of KLH, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow KLH: new trials by email Literature Review of KLH trials Research Report on KLH

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis
23-PPV, 13-PCV Booster, Influenza Vaccine - Multiple Sclerosis, Relapsing-Remitting
Phase 3CompletedHoffmann-La Roche1022015-10-272024-03-26
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
Rindopepimut (CDX-110) with GM-CSF, Temozolomide, KLH - Glioblastoma, Small Cell Glioblastoma
Phase 3CompletedCelldex Therapeutics7452011-11-012018-01-16

Conditions studied

Brain Neoplasms (1)  ·  Glioblastoma (1)  ·  Gliosarcoma (1)  ·  Multiple Sclerosis, Relapsing-Remitting (1)  ·  Neoplasms (1)

Sponsors

Celldex Therapeutics (1)  ·  Hoffmann-La Roche (1)

Countries

Canada (2)  ·  United States (2)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Colombia (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Hungary (1)  ·  India (1)  ·  Israel (1)  ·  Italy (1)

Results publications

PMID 28844499, PMID 32727835, PMID 36346112

NIH funding

2015 (1)